Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.45 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15153687 | 1.00 | LMNA (0.50) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| SCHEMBL10944728 | 0.98 | LMNA (0.52) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| SCHEMBL3100157 | 0.98 | LMNA (0.52) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| SCHEMBL11283608 | 0.98 | LMNA (0.52) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| SCHEMBL11279244 | 0.98 | LMNA (0.52) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| Adipic Acid SCHEMBL7050293 | 0.98 | LMNA (0.52) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| SCHEMBL12355088 | 0.93 | CAMK2A (0.46) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| SCHEMBL1244924 | 0.93 | CAMK2A (0.46) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| SCHEMBL10618648 | 0.92 | FFAR4 (0.61) | LMNAFFAR4FFAR1TSHRNFKB1 | |
| Adipic Acid SCHEMBL9319144 | 0.91 | FFAR1 (0.54) | LMNAFFAR4FFAR1TSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1221851-B2 | ANTIVIRAL COMPOSITIONS FOR TISSUE PAPER | PROCTER & GAMBLE (US) | 2011-10-12 | — | — | EP | disclosed |
| US-7776365-B2 | Article with skin protecting and moisturizing compound | SAKURA PROPERTIES, LLC (US) | 2010-08-17 | — | — | US | disclosed |
| EP-1189506-B2 | TISSUE PRODUCTS HAVING ANTIVIRAL PROPERTIES | PROCTER & GAMBLE (US) | 2007-11-21 | — | — | EP | disclosed |
| WO-2007084721-A2 | SKIN PROTECTION AND MOISTURIZING COMPOSITIONS AND METHODS | SAKURA PROPERTIES, LLC (US) | 2007-07-26 | — | — | WO | disclosed |
| US-20060210516-A1 | ARTICLE WITH SKIN PROTECTING AND MOISTURIZING COMPOUND | SAKURA PROPERTIES, LLC | 2006-09-21 | — | — | US | disclosed |
| EP-1238159-B1 | TISSUE PRODUCTS CONTAINING ANTIVIRAL AGENTS WHICH ARE MILD TO THE SKIN | PROCTER & GAMBLE (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-1221851-B1 | ANTIVIRAL COMPOSITIONS FOR TISSUE PAPER | PROCTER & GAMBLE (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-1061799-B1 | TISSUE PAPER HAVING ANTIMICROBIAL SKIN LOTION | PROCTER & GAMBLE (US) | 2004-04-28 | — | — | EP | disclosed |
| EP-1189506-B1 | TISSUE PRODUCTS HAVING ANTIVIRAL PROPERTIES | PROCTER & GAMBLE (US) | 2004-04-21 | — | — | EP | disclosed |
| US-6517849-B1 | Adding pyrrolidone carboxylic acid | THE PROCTER & GAMBLE COMPANY | 2003-02-11 | — | — | US | disclosed |
| EP-1238159-A1 | TISSUE PRODUCTS CONTAINING ANTIVIRAL AGENTS WHICH ARE MILD TO THE SKIN | THE PROCTER & GAMBLE COMPANY (US) | 2002-09-11 | — | — | EP | disclosed |
| EP-1221851-A2 | ANTIVIRAL COMPOSITIONS FOR TISSUE PAPER | THE PROCTER & GAMBLE COMPANY (US) | 2002-07-17 | — | — | EP | disclosed |
| US-20020064542-A1 | TISSUE PRODUCTS UTILIZING WATER SOLUBLE FILMS AS CARRIERS FOR ANTIVIRAL COMPOSITIONS AND PROCESS FOR MAKING | PROCTER & GAMBLE COMPANY, THE | 2002-05-30 | — | — | US | disclosed |
| EP-1189506-A1 | TISSUE PRODUCTS HAVING ANTIVIRAL PROPERTIES | THE PROCTER & GAMBLE COMPANY (US) | 2002-03-27 | — | — | EP | disclosed |
| US-6238682-B1 | TISSUE PAPER CONTAINING LOTION | THE PROCTER & GAMBLE COMPANY | 2001-05-29 | — | — | US | disclosed |
| WO-2001029315-A1 | TISSUE PRODUCTS CONTAINING ANTIVIRAL AGENTS WHICH ARE MILD TO THE SKIN | THE PROCTER & GAMBLE COMPANY (US) | 2001-04-26 | — | — | WO | disclosed |
| WO-2001028337-A2 | ANTIVIRAL COMPOSITIONS FOR TISSUE PAPER | THE PROCTER & GAMBLE COMPANY (US) | 2001-04-26 | — | — | WO | disclosed |
| WO-2001000023-A1 | TISSUE PRODUCTS HAVING ANTIVIRAL PROPERTIES | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-04 | — | — | WO | disclosed |
| EP-1061799-A1 | TISSUE PAPER HAVING ANTIMICROBIAL SKIN LOTION | THE PROCTER & GAMBLE COMPANY (US) | 2000-12-27 | — | — | EP | disclosed |
| WO-1999045771-A1 | TISSUE PAPER HAVING ANTIMICROBIAL SKIN LOTION | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020064542-A1 | TISSUE PRODUCTS UTILIZING WATER SOLUBLE FILMS AS CARRIERS FOR ANTIVIRAL COMPOSITIONS AND PROCESS FOR MAKING | SAMHD1, CUTA, TK1 | LMNA 3380/4885FFAR4 4297/4885FFAR1 3976/4885 |
| US-20060210516-A1 | ARTICLE WITH SKIN PROTECTING AND MOISTURIZING COMPOUND | FUCA1, DSG1, FUCA2 | LMNA 3656/4885FFAR4 2335/4885FFAR1 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.